RxDoctor Payments Data

Linda Martin, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Charlottesville, VANPI 1841392164

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $50,972 of the $76,471 with a category attached, or 66.7%. 14 manufacturers reported payments, led by AstraZeneca at 41.3% of the total. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,471in general payments, 2019–2025

Across 140 payments — averaging $546.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$32K
  • Genentech USA, Inc.$9K
  • Intuitive Surgical$8K
  • Johnson & Johnson$6K
  • Medical Device Business Services, Inc.$6K
  • Medtronic$4K
  • plus $11K from 8 others
$220,187in research payments, 2019–2025

Across 16 payments — averaging $13,762 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$148K
  • Ethicon Endo-surgery Inc.$72K

What the payments were for

  • Consulting fees$50,97267%
  • Speaking & faculty fees$7,0809%
  • Grants$2,7934%
  • Travel & lodging$4,9546%
  • Food & beverage$5,1647%
  • Education$5,5097%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,471 in reported general payments places this provider in the 95th percentile of 109 thoracic surgery (cardiothoracic vascular surgery) providers in Virginia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Virginia

Medicare billing

Part B allowed, 2024
$99,963
Medicare patients
124
Services billed
264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →